EUVIMEDEUVIMED entdecken
Crossref

Imbalances in the immunostaining of TLR2 and TLR4, and their respective second messengers, impair the prognosis of oral squamous cell carcinoma

Isaac Müller de Sousa Maia, Natasha Tavares Cavalcante Rebouças, Laís Oliveira de Castro Barroso, Ana Beatriz Silva Marques Araújo, Gabriel Santos Sousa, André Alves Crispim, Maria Cláudia Dos Santos Luciano, Dayrine Silveira de Paula, Paulo Goberlânio de Barros Silva

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · 2026

DOI: 10.1016/j.oooo.2026.04.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2026. Verfasst von Isaac Müller de Sousa Maia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute of Ceará, Department of Genetics, Fortaleza, Ceará, Brazil. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Toll-Like Receptor 2, Toll-Like Receptor 4, Mouth Neoplasms. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development, Northeast Bank.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the influence of immunostaining for Toll-like receptors (TLR) 2 and 4 and their second messengers in the prognosis of oral squamous cell carcinoma (OSCC). STUDY DESIGN: 220 cases of OSCC undergoing surgical treatment, with or without adjuvant therapy, were included, from which clinicopathological and disease-free survival (DFS) data were retrieved. The samples underwent tissue microarray technique and immunohistochemistry for TLR2, TLR4, and their second messengers, MyD88, IκB, NF-κB p65, and Ki-67. The percentage of immunostained cells was associated with clinicopathologic and prognostic data using the chi-square test, the Log-rank Mantel-Cox test, and a Cox regression model (SPSS, v20.0; p < .05). RESULTS: The DFS had a median of 19.00 months (95% CI = 15.12-22.68). The loss of cytoplasmic expression of TLR2 (p = .021) and nuclear expression of TLR4 (p = .015), NF-κB p65 (p = .002), IκB (p = .008), and MyD88 (p = .001) negatively impacted DFS. Other clinical characteristics, such as diabetes mellitus (p = .017), smoking (p = .015), lymph node metastasis (pN+) (p = .048), compromised margins (p = .001), presence of ulceration (p = .049), and low infiltration of stromal-infiltrating lymphocytes (p = .018), were directly related to worse DFS. In multivariate analysis, diabetes mellitus (p = .003), compromised margins (p = .004) and low expression of cytoplasmic TLR4 (p = .041) demonstrated an increased risk of recurrence (RR). Additionally, TLR4 and TLR2 are directly correlated with iKB (r = 0.389 and 0.244), NFkB p65 (r = 0.255 and 0.315) and MyD88 (r = 0.420 and r = 0.325), and MyD88 reduced the ki67 immunostaining (r = -0.162). CONCLUSION: Low staining of TLR expression may be associated with poorer tumor differentiation and a worse prognosis, due to reduced local immune response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellToll-Like Receptor 2Toll-Like Receptor 4Mouth NeoplasmsHumansFemalePrognosisImmunohistochemistryMaleMiddle AgedBiomarkers, TumorAgedDisease-Free SurvivalNeoplasm StagingTissue Array AnalysisAdult

Substanzen

Toll-Like Receptor 2Toll-Like Receptor 4TLR4 protein, humanTLR2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Cancer Institute of Ceará, Department of Genetics, Fortaleza, Ceará, Brazil.
  • Cancer Institute of Ceará, Department of Genetics, Fortaleza, Ceará, Brazil; Unichristus, Department of Dentistry, Fortaleza, Ceará, Brazil.
  • Unichristus, Department of Dentistry, Fortaleza, Ceará, Brazil.
  • Cancer Institute of Ceará, Department of Genetics, Fortaleza, Ceará, Brazil; Unichristus, Department of Dentistry, Fortaleza, Ceará, Brazil. Electronic address: paulo_goberlanio@yahoo.com.br.

Förderung

  • National Council for Scientific and Technological Development
  • Northeast Bank

Zitieren

APA

de Sousa Maia, I. M., Rebouças, N. T. C., de Castro Barroso, L. O., Araújo, A. B. S. M., Sousa, G. S., Crispim, A. A., Dos Santos Luciano, M. C., de Paula, D. S., & de Barros Silva, P. G. (2026). Imbalances in the immunostaining of TLR2 and TLR4, and their respective second messengers, impair the prognosis of oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. https://doi.org/10.1016/j.oooo.2026.04.013

Vancouver

de Sousa Maia IM, Rebouças NTC, de Castro Barroso LO, Araújo ABSM, Sousa GS, Crispim AA, et al. Imbalances in the immunostaining of TLR2 and TLR4, and their respective second messengers, impair the prognosis of oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2026. doi:10.1016/j.oooo.2026.04.013

BibTeX
@article{deSousaMaia2026,
  author = {de Sousa Maia, Isaac Müller and Rebouças, Natasha Tavares Cavalcante and de Castro Barroso, Laís Oliveira and Araújo, Ana Beatriz Silva Marques and Sousa, Gabriel Santos and Crispim, André Alves and Dos Santos Luciano, Maria Cláudia and de Paula, Dayrine Silveira and de Barros Silva, Paulo Goberlânio},
  title = {Imbalances in the immunostaining of TLR2 and TLR4, and their respective second messengers, impair the prognosis of oral squamous cell carcinoma},
  journal = {Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology},
  year = {2026},
  doi = {10.1016/j.oooo.2026.04.013}
}
Kostenlos starten →